JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 8 1320-1327
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mäki, M. T.
Right arrow Articles by Knuuti, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mäki, M. T.
Right arrow Articles by Knuuti, J. M.

Free Fatty Acid Uptake in the Myocardium and Skeletal Muscle Using Fluorine-18-Fluoro-6-Thia-Heptadecanoic Acid

Maija T. Mäki, Merja Haaparanta, Pirjo Nuutila, Vesa Oikonen, Matti Luolahti, Olli Eskola and Juhani M. Knuuti

Departments of Nuclear Medicine, Medicine and Clinical Physiology, and Radiochemistry Laboratory, University of Turku, Turku; Turku PET Centre, Turku, Finland

Correspondence: For correspondence or reprints contact: Maija T. Mäki, MD, Turku PET Centre, University of Turku, FIN-20520, Turku, Finland.

ABSTRACT

14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid (FTHA) has been recently introduced as a new tracer for fatty acid metabolism. Myocardial [18F]FTHA uptake is believed to reflect mainly beta-oxidation of the circulating free fatty acids (FFAs), since it is trapped in the mitochondria because subsequent steps of beta-oxidation are inhibited by sulfur heteroatom. We investigated [18F]FTHA kinetics in myocardial and skeletal muscle in vivo. Methods: Two dynamic PET studies were performed in seven patients with stable coronary artery disease, once in the fasting state and once during euglycemic hyperinsulinemia (serum insulin ~60 mU/liter). The fractional [18F] FTHA uptake rates (Ki) were multiplied with serum FFA concentra tions and were considered to represent FFA uptake. Results: Serum FFA concentration decreased by 80% during insulin clamp. After tracer injection, rapid myocardial uptake was identified both in the fasting state and during insulin stimulation. The cardiac image quality was excellent in both occasions. In addition, femoral muscles were clearly visualized in both studies. The fractional myocardial [18F]FTHA uptake rates (Ki) in the normal myocardial regions were similar in the fasting state (0.11 ± 0.04 ml/g/min (mean ± s.d.) and during insulin clamp (0.12 ± 0.03 ml/g/min;ns). The calculated myocardial FFA uptake was four times higher in the fasting state than during insulin clamp (5.8 ± 1.7 versus 1.4 ± 0.5 /xmol/100 g/min, p < 0.005). The femoral muscle fractional [18F]FTHA uptake rates (Ki) were lower (0.0071 ± 0.0014 ml/g/min) in the fasting state than during insulin clamp (0.0127 ± 0.0036 ml/g/min;p = 0.03), but the estimated femoral muscle FFA uptake was three times higher in the fasting state (0.38 ± 0.09 /u.mol/100 g/min) as compared to that during insulin clamp (0.12 ± 0.05 µmol/100 g/min, p < 0.005). Conclusion: Fluorine-18-FTHA PET appears to be a feasible method to estimate fatty acid kinetics in myocardial and skeletal muscle. Physiologically reasonable rates of FFA uptake in myocardium and skeletal muscle were obtained. Furthermore, the uptake rates were suppressed in response to insulin both in the myocardial and femoral muscle as expected.

Key Words: free fatty acids • fluorine-18-fluoro-6-thia-heptade-canoic acid • muscle • myocardium • PET




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Clark
Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle
Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E732 - E750.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. Guiducci, T. Gronroos, M. J. Jarvisalo, J. Kiss, A. Viljanen, A. G. Naum, T. Viljanen, T. Savunen, J. Knuuti, E. Ferrannini, et al.
Biodistribution of the Fatty Acid Analogue 18F-FTHA: Plasma and Tissue Partitioning Between Lipid Pools During Fasting and Hyperinsulinemia
J. Nucl. Med., March 1, 2007; 48(3): 455 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. C. Hannukainen, P. Nuutila, B. Ronald, J. Kaprio, U. M. Kujala, T. Janatuinen, O. J. Heinonen, J. Kapanen, T. Viljanen, M. Haaparanta, et al.
Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins
J. Physiol., January 1, 2007; 578(1): 347 - 358.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. C. Hannukainen, P. Nuutila, J. Kaprio, O. J Heinonen, U. M. Kujala, T. Janatuinen, T. Ronnemaa, J. Kapanen, M. Haaparanta-Solin, T. Viljanen, et al.
Relationship between local perfusion and FFA uptake in human skeletal muscle--no effect of increased physical activity and aerobic fitness
J Appl Physiol, November 1, 2006; 101(5): 1303 - 1311.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Shearer, P. T. Fueger, J. N. Rottman, D. P. Bracy, P. H. Martin, and D. H. Wasserman
AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo
Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E871 - E877.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Iozzo, T. Takala, V. Oikonen, J. Bergman, T. Gronroos, E. Ferrannini, P. Nuutila, and J. Knuuti
Effect of Training Status on Regional Disposal of Circulating Free Fatty Acids in the Liver and Skeletal Muscle During Physiological Hyperinsulinemia
Diabetes Care, September 1, 2004; 27(9): 2172 - 2177.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Iozzo, A. K. Turpeinen, T. Takala, V. Oikonen, J. Bergman, T. Gronroos, E. Ferrannini, P. Nuutila, and J. Knuuti
Defective Liver Disposal of Free Fatty Acids in Patients with Impaired Glucose Tolerance
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3496 - 3502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. N. Rottman, D. Bracy, C. Malabanan, Z. Yue, J. Clanton, and D. H. Wasserman
Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E116 - E123.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. R. Wallhaus, M. Taylor, T. R. DeGrado, D. C. Russell, P. Stanko, R. J. Nickles, and C. K. Stone
Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure
Circulation, May 22, 2001; 103(20): 2441 - 2446.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Taylor, T. R. Wallhaus, T. R. DeGrado, D. C. Russell, P. Stanko, R. J. Nickles, and C. K. Stone
An Evaluation of Myocardial Fatty Acid and Glucose Uptake Using PET with [18F]Fluoro-6-Thia-Heptadecanoic Acid and [18F]FDG in Patients with Congestive Heart Failure
J. Nucl. Med., January 1, 2001; 42(1): 55 - 62.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. O. Takala, P. Nuutila, C. Katoh, M. Luotolahti, J. Bergman, M. Maki, V. Oikonen, U. Ruotsalainen, T. Gronroos, M. Haaparanta, et al.
Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation
Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E585 - E590.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. O. Takala, P. Nuutila, J. Knuuti, M. Luotolahti, and H. Yki-Jarvinen
Insulin action on heart and skeletal muscle glucose uptake in weight lifters and endurance athletes
Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E706 - E711.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.